Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Michelet

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Clinical Pharmacokinetics|November 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)Marian Klose, Ilaria Colombo, Katrin Gobat, et al.
Clinical Pharmacology and Therapeutics|June 25, 2020
Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation ApproachAnna Mueller-Schoell, Lena Klopp-Schulze, Werner Schroth, et al.
Clinical Pharmacokinetics|December 25, 2024
A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the ElderlyDaming Kong, Jason A Roberts, Jeffrey Lipman, et al.
Clinical Pharmacology and Therapeutics|March 18, 2024
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM CohortAnna M Mc Laughlin, Thomas Helland, Fenja Klima, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Clinical Pharmacokinetics|November 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)Marian Klose, Ilaria Colombo, Katrin Gobat, et al.
Clinical Pharmacology and Therapeutics|June 25, 2020
Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation ApproachAnna Mueller-Schoell, Lena Klopp-Schulze, Werner Schroth, et al.
Clinical Pharmacokinetics|December 25, 2024
A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the ElderlyDaming Kong, Jason A Roberts, Jeffrey Lipman, et al.
Clinical Pharmacology and Therapeutics|March 18, 2024
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM CohortAnna M Mc Laughlin, Thomas Helland, Fenja Klima, et al.
Pageof 8